Perip7lakin is a target for autoimmunity in asthma

Area of Science:

• Immunology
• Pulmonology
• Dermatology

Background:

• Autoimmunity targeting epithelial antigens is implicated in asthma, especially severe and non-atopic forms.
• Periplakin, a desmosomal protein crucial for epithelial integrity and signaling, is investigated as a potential autoantigen.
• Previous research suggested a role for autoimmunity in asthma, but specific epithelial targets remained elusive.

Discussion:

• This study detected anti-periplakin IgG antibodies in 18% of asthma patients, independent of severity or atopy.
• Anti-periplakin IgE antibodies were found in 8.7% of tested patients, with a higher prevalence in those with nasal polyposis.
• These findings highlight periplakin as a novel epithelial autoantigen in asthma.

Key Insights:

• Identification of anti-periplakin IgG and IgE autoantibodies in a significant subset of asthma patients.
• Association of anti-periplakin IgE with nasal polyposis suggests a potential link between upper and lower airway autoimmunity.
• The study establishes periplakin autoimmunity as a new avenue for asthma research.

Outlook:

• Further longitudinal studies are required to elucidate the role of periplakin autoimmunity in asthma development and progression.
• Investigating the functional consequences of anti-periplakin antibodies on airway epithelium is crucial.
• Exploring therapeutic strategies targeting periplakin autoimmunity could offer new treatment options for specific asthma phenotypes.